Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Holt

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Identification of genes expressed in premalignant breast disease by microscopy-directed cloningR A Jensen, D L Page, J T Holt
Molecular and Cellular Biology|February 1, 1988
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiationJ T Holt, R L Redner, A W Nienhuis
Human Gene Therapy|April 29, 1998
Antisense c-myc retroviral vector suppresses established human prostate cancerM S Steiner, C T Anthony, Y Lu, et al.
Human Gene Therapy|July 10, 1996
Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNAJ T Holt, C B Arteaga, D Robertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferationJ T Holt, T V Gopal, A D Moulton, et al.
Journal of Cellular Biochemistry|February 1, 1991
Antisense inhibition of c-myc expression reveals common and distinct mechanisms of growth inhibition by TGF beta and TNF alphaC Robinson-Benion, K E Salhany, S R Hann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferationJ A Pietenpol, J T Holt, R W Stein, et al.
Hematology/Oncology Clinics of North America|July 31, 1998
Ovarian cancer gene therapyD L Tait, P S Obermiller, R A Jensen, et al.
The Journal of Pathology|November 20, 2008
Oestrogen-mediated phosphorylation and stabilization of BRCA2 protein in breastJ L Malone, A C Nelson, R Lieberman, et al.
Transfusion|March 1, 1983
A technetium-99m red cell survival technique for in vivo compatibility testingJ T Holt, S L Spitalnik, A E McMican, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Identification of genes expressed in premalignant breast disease by microscopy-directed cloningR A Jensen, D L Page, J T Holt
Molecular and Cellular Biology|February 1, 1988
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiationJ T Holt, R L Redner, A W Nienhuis
Human Gene Therapy|April 29, 1998
Antisense c-myc retroviral vector suppresses established human prostate cancerM S Steiner, C T Anthony, Y Lu, et al.
Human Gene Therapy|July 10, 1996
Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNAJ T Holt, C B Arteaga, D Robertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferationJ T Holt, T V Gopal, A D Moulton, et al.
Journal of Cellular Biochemistry|February 1, 1991
Antisense inhibition of c-myc expression reveals common and distinct mechanisms of growth inhibition by TGF beta and TNF alphaC Robinson-Benion, K E Salhany, S R Hann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferationJ A Pietenpol, J T Holt, R W Stein, et al.
Hematology/Oncology Clinics of North America|July 31, 1998
Ovarian cancer gene therapyD L Tait, P S Obermiller, R A Jensen, et al.
The Journal of Pathology|November 20, 2008
Oestrogen-mediated phosphorylation and stabilization of BRCA2 protein in breastJ L Malone, A C Nelson, R Lieberman, et al.
Transfusion|March 1, 1983
A technetium-99m red cell survival technique for in vivo compatibility testingJ T Holt, S L Spitalnik, A E McMican, et al.
Pageof 6